Download PDF
- Glenmark Pharmaceuticals Limited
- Overview
- Last Modified:
- September 9, 2025
- Company type:
- Public
- Industry:
- Pharmaceutical
- Verified:
- No
- No of Employees:
- 1 001 - 10 000
- Stock Code:
- GLENMARK
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Mumbai, India
- Public Interest Score:
- 750+
- Glenmark Pharmaceuticals Limited
- General Information
Description
Glenmark Pharmaceuticals is a global, innovation-led pharmaceutical company focused on research and development of new chemical and biological entities (NCEs and NBEs) and branded generics, with a strong presence in emerging markets and a significant generics business in the US. The company has a global network of manufacturing facilities and R&D centers, and is known for its work on various therapeutic areas through its subsidiaries, including a formerly separate company named Glenmark Life Sciences, which has now rebranded as Alivus Life Sciences Ltd
Glenn Saldanha:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Cherylann Pinto:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Blanche Saldanha:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Rajesh Desai:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Saira Ramasastry:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Dipankar Bhattacharjee:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Vijayalakshmi Iyer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anurag Mantri:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Pradeep Kumar Sinha:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patricia Andrews:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Cherylann Pinto:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Blanche Saldanha:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Rajesh Desai:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Saira Ramasastry:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Dipankar Bhattacharjee:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Vijayalakshmi Iyer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anurag Mantri:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Pradeep Kumar Sinha:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patricia Andrews:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 15159
- Founded Year:
- 1977
- Registration Number:
- L24299MH1977PLC019982
- Country:
- India
- Stock Exchanges:
-
- India National Stock Exchange
- Financial year end:
- March
- No. of Countries operations:
- 80
- Company Status:
- In Business
- Industry Sub Category:
- Date listed on Stock Exchange:
- 06/08/2021
- Contact Information
- Business operation:
- Our commercial operations span across 80 countries including India, US, Europe, Asia, Africa, Latin America and other emerging markets. A number of our products are market leaders in our focus therapy areas such as dermatology, respiratory and cardio metabolic.
- Primary office:
- Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Sanjay Chaudari
- Reporting currency:
- INR
- ISIN number (12 digit):
NSE
INE935A01035- Authorised shares:
- 2 370 000 000
- Issued shares:
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 1 shareholder
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Fitch | ![]() | United States of America | New York, New York, United States | BB |
| S&P Global | ![]() | United States of America | New York | BB+ |
Countries Operations/ Offices
Company Directors
Name
Nationality
Age
Role
Qualification
Name
Saira
Non ExecutiveNationalityIndia
RoleNED
QualificationB.A. (Economics), MA(Management science and Engineering)
Name
Dipankar
Non ExecutiveNationalityIndia
RoleNED
QualificationGraduate Degree , Undergraduate Degree
Name
Pradeep
Non ExecutiveNationalityIndia
70
RoleChairperson
QualificationMasters in Economics , M. Phil in Social Sciences
Directors Tenure
Name
Duration
Director Experience
Name
Experience
Company Auditors
Name
Date Appointed
Years
Name
Other
Date Appointed01/01/2021
Year4 years and 10 months
Company Past Directors
Name
ED/NED
Role
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|







